231 related articles for article (PubMed ID: 12209660)
21. Association between sexual behavior and cervical cancer screening.
Smith AM; Heywood W; Ryall R; Shelley JM; Pitts MK; Richters J; Simpson JM; Patrick K
J Womens Health (Larchmt); 2011 Jul; 20(7):1091-6. PubMed ID: 21682554
[TBL] [Abstract][Full Text] [Related]
22. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
23. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
24. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
25. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
27. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
[TBL] [Abstract][Full Text] [Related]
28. Cytological screening for cervical cancer in the province of Limburg, Belgium.
Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
Couzos S; Wronski I; Murray R; Cox H
Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
[TBL] [Abstract][Full Text] [Related]
30. An audit of the cervical cancer screening histories of 246 women with carcinoma.
Duggan MA; Nation J
J Low Genit Tract Dis; 2012 Jul; 16(3):263-70. PubMed ID: 22297213
[TBL] [Abstract][Full Text] [Related]
31. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
32. The Papanicolaou smear as a sentinel screening test for health screening in women.
Hueston WJ; Stiles MA
Arch Intern Med; 1994 Jul; 154(13):1473-7. PubMed ID: 8018002
[TBL] [Abstract][Full Text] [Related]
33. An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix.
Nasca PC; Ellish N; Caputo TA; Saboda K; Metzger B
N Y State J Med; 1991 Apr; 91(4):152-6. PubMed ID: 2047031
[TBL] [Abstract][Full Text] [Related]
34. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy.
Campbell E; Peterkin D; Abbott R; Rogers J
Prev Med; 1997; 26(6):801-7. PubMed ID: 9388791
[TBL] [Abstract][Full Text] [Related]
35. Impact of a new cervical pap smear screening guideline on member perceptions and comfort levels.
Rolnick SJ; LaFerla JJ; Jackson J; Akkerman D; Compo R
Prev Med; 1999 May; 28(5):530-4. PubMed ID: 10329344
[TBL] [Abstract][Full Text] [Related]
36. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer.
Norman SA; Talbott EO; Kuller LH; Stolley PD; Dunn MS; Baffone K; Klionsky B; Weinberg GB
Arch Intern Med; 1991 Jan; 151(1):58-64. PubMed ID: 1985610
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
Buehler SK; Parsons WL
CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
[TBL] [Abstract][Full Text] [Related]
38. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
[TBL] [Abstract][Full Text] [Related]
39. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
[TBL] [Abstract][Full Text] [Related]
40. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
